S&P/ASX 200 set to jump: 7 shares to watch

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is expected to trade higher today following positive leads from international markets.

Here’s a recap:

  • FTSE 100 (UK): up 1.03%
  • DAX (Germany): up 0.18%
  • CAC 40 (France): up 0.04%
  • Dow Jones (USA): up 0.64%
  • NASDAQ (USA): up 0.53%

In London, mining shares pushed the market higher as new polls showed the Brexit gaining ground. FTSE-listed shares of BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) rose 6.2% and 6.4%, respectively.

US markets also finished higher following comments by Fed Chair Janet Yellen, who again hinted at possible interest rates hikes this year. The energy and materials sectors were best-performing.

Closer to home, the Sydney Futures Exchange is tipping a 15-point, or 0.3%, rise from the S&P/ASX 200.

Shares in focus will include Mayne Pharma Group Ltd (ASX: MYX). This morning, Mayne Pharma announced the US FDA had granted approval of its ANDA for dofetilide capsules in the US. As a result, Mayne Pharma said it has been granted 180-day market exclusivity and will immediately commence commercial launch.

After a significant rally in gold shares yesterday, shares of miners Northern Star Resources Ltd (ASX: NST), EVOLUTION FPO (ASX: EVN) and Newcrest Mining Limited (ASX: NCM) will again be in focus.

Finally, in broker news:

  • Morgans analysts cut their Cardno Limited (ASX: CDD) price target 9% to $5.34;
  • Deutsche Bank analysts raised their ALS Ltd (ASX: ORE) share price target 81% to $5.30; and,
  • Morgan Stanley analysts raised their Healthscope Ltd (ASX: HSO) price target 14% to $2.87, according to Dow Jones Newswires.

This stock is a 'Buy'

I'm looking for other - faster growing - dividend shares to add to my portfolio, like the one The Motley Fool's expert analysts hand-picked as their best dividend share idea for 2016.

Indeed, our resident dividend experts named their Top Dividend Share for 2016. Not only are the shares dirt cheap, the company is growing and trading on a 5.6% fully franked dividend yield. Simply click here to gain access to this comprehensive FREE investment report, including the name of this fast growing ASX dividend share. No credit card required!

Motley Fool Contributor Owen Raszkiewicz does not have a financial interest in any company mentioned in this article. Owen welcomes -- and encourages -- your feedback on Google+, LinkedIn or you can follow him on Twitter @ASXinvest.

The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.